CY1679A - Stabilization of antibiotic compositions with salts - Google Patents

Stabilization of antibiotic compositions with salts

Info

Publication number
CY1679A
CY1679A CY1679A CY167993A CY1679A CY 1679 A CY1679 A CY 1679A CY 1679 A CY1679 A CY 1679A CY 167993 A CY167993 A CY 167993A CY 1679 A CY1679 A CY 1679A
Authority
CY
Cyprus
Prior art keywords
stabilization
salts
antibiotic compositions
antibiotic
compositions
Prior art date
Application number
CY1679A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1679A publication Critical patent/CY1679A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
CY1679A 1987-01-09 1993-10-10 Stabilization of antibiotic compositions with salts CY1679A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/001,945 US4808617A (en) 1985-12-18 1987-01-09 Lyophilized or precipitated cephalosporin zwitterion and salt combination

Publications (1)

Publication Number Publication Date
CY1679A true CY1679A (en) 1993-10-10

Family

ID=21698538

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1679A CY1679A (en) 1987-01-09 1993-10-10 Stabilization of antibiotic compositions with salts

Country Status (33)

Country Link
US (1) US4808617A (es)
JP (1) JP2568226B2 (es)
KR (1) KR950010154B1 (es)
AR (1) AR243501A1 (es)
AT (1) AT388672B (es)
AU (1) AU606361B2 (es)
BE (1) BE1002114A3 (es)
CA (1) CA1307464C (es)
CH (1) CH676202A5 (es)
CS (1) CS265249B2 (es)
CY (1) CY1679A (es)
DD (1) DD264614A5 (es)
DE (1) DE3740588C2 (es)
DK (1) DK166404B1 (es)
ES (1) ES2008951A6 (es)
FI (1) FI89006C (es)
FR (1) FR2609396B1 (es)
GB (1) GB2199746B (es)
GR (1) GR871860B (es)
HK (1) HK5593A (es)
HU (1) HU199686B (es)
IE (1) IE61238B1 (es)
IL (1) IL84346A (es)
IT (1) IT1215666B (es)
LU (1) LU87102A1 (es)
NL (1) NL193266C (es)
OA (1) OA08796A (es)
PT (1) PT86157B (es)
SE (1) SE467910B (es)
SG (1) SG114792G (es)
SU (1) SU1575942A3 (es)
YU (1) YU46689B (es)
ZA (1) ZA88114B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
WO2006109324A2 (en) * 2005-04-13 2006-10-19 Lupin Limited Processes for preparation of amorphous cefepime acid addition salts
JP5491119B2 (ja) * 2009-10-02 2014-05-14 日東電工株式会社 薬物含有微粒子を含む医薬組成物およびその製造方法
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2016035846A1 (ja) 2014-09-04 2016-03-10 塩野義製薬株式会社 カテコール基を有するセファロスポリン類を含有する製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953439A (en) * 1973-08-01 1976-04-27 Smithkline Corporation Substituted phenylglycylcephalosporins
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables

Also Published As

Publication number Publication date
IE61238B1 (en) 1994-10-19
NL193266C (nl) 1999-05-06
LU87102A1 (fr) 1988-08-23
IL84346A0 (en) 1988-04-29
NL193266B (nl) 1999-01-04
AT388672B (de) 1989-08-10
AU8085687A (en) 1989-05-11
CS15888A2 (en) 1989-01-12
DK577387A (da) 1988-07-10
KR950010154B1 (ko) 1995-09-11
JP2568226B2 (ja) 1996-12-25
ZA88114B (es) 1988-06-27
KR880008811A (ko) 1988-09-13
IE872970L (en) 1988-07-09
PT86157B (pt) 1991-02-08
DK577387D0 (da) 1987-11-03
PT86157A (en) 1987-12-01
IT8819013A0 (it) 1988-01-07
CA1307464C (en) 1992-09-15
DE3740588A1 (de) 1988-07-21
AR243501A1 (es) 1993-08-31
IT1215666B (it) 1990-02-22
GR871860B (en) 1988-05-10
HK5593A (en) 1993-02-05
JPS63208522A (ja) 1988-08-30
SE467910B (sv) 1992-10-05
CS265249B2 (en) 1989-10-13
ES2008951A6 (es) 1989-08-16
NL8800025A (nl) 1988-08-01
DK166404B1 (da) 1993-05-17
ATA341687A (de) 1989-01-15
YU46689B (sh) 1994-04-05
SG114792G (en) 1992-12-24
DE3740588C2 (de) 1996-07-11
IL84346A (en) 1992-05-25
FI89006C (fi) 1993-08-10
AU606361B2 (en) 1991-02-07
SE8800036L (sv) 1988-07-10
FI875122A0 (fi) 1987-11-19
GB2199746A (en) 1988-07-20
GB8725875D0 (en) 1987-12-09
FR2609396B1 (fr) 1993-01-29
OA08796A (fr) 1989-03-31
HU199686B (en) 1990-03-28
YU2388A (en) 1989-10-31
FR2609396A1 (fr) 1988-07-15
SU1575942A3 (ru) 1990-06-30
SE8800036D0 (sv) 1988-01-08
US4808617A (en) 1989-02-28
GB2199746B (en) 1990-10-24
FI875122A (fi) 1988-07-10
DD264614A5 (de) 1989-02-08
FI89006B (fi) 1993-04-30
HUT46223A (en) 1988-10-28
CH676202A5 (es) 1990-12-28
BE1002114A3 (fr) 1990-07-10

Similar Documents

Publication Publication Date Title
ZA886410B (en) Crystalline aluminumphosphate compositions
JPS6434980A (en) Piperidine-triazine compound and use as stabilizer
IL87606A (en) Crystalline aluminumphosphate compositions
GB8713769D0 (en) Compositions of matter
SG114792G (en) Stabilization of antibiotic compositions with salts
PH23045A (en) Cephem derivative and composition containing said compound
NZ211594A (en) The preparation of certain cephalosporin derivatives
AR243894A1 (es) Metodo para preparar sales cristalinas estables de cefalosporinas utiles para formular composiciones inyectables.
ZA882963B (en) New ophtalmological composition of matter
IL86745A0 (en) Analgesic compositions containing derivatives of dioxopiperidine
ZA861574B (en) Nucleation of urethane compositions
GB8715966D0 (en) Compositions of matter
HK42595A (en) Crystalline cephalosporin antibiotics
NZ222962A (en) Stable antibiotic ester feed compositions
GR3000526T3 (en) Therapeutical compositions containing benzhydryl thiomethane derivatives
IL85392A0 (en) 27-halo derivatives of ll-f28249 compounds
GB2206491B (en) Anti-anxiogenic compositions containing dioxopiperidine derivatives
GB8712396D0 (en) Composition of matter
GB8705183D0 (en) Compositions of matter
GB8703068D0 (en) Compositions of matter
IL80474A0 (en) Crystalline cephalosporin monohydrate
GB8704839D0 (en) Compound compositions
GB8727088D0 (en) Synergistic antibiotic composition
CS232187A1 (en) Retardation composition of milisecunde type
GB8724192D0 (en) Composition of matter